1. Sawynok J. Adenosine receptor activation and nociception. Eur J Pharmacol. 1998; 347:1–11. PMID:
9650842.
Article
2. Sollevi A. Adenosine for pain control. Acta Anaesthesiol Scand Suppl. 1997; 110:135–136. PMID:
9248564.
Article
3. Gan TJ, Habib AS. Adenosine as a non-opioid analgesic in the perioperative setting. Anesth Analg. 2007; 105:487–494. PMID:
17646510.
Article
4. Segerdahl M, Ekblom A, Sandelin K, Wickman M, Sollevi A. Peroperative adenosine infusion reduces the requirements for isoflurane and postoperative analgesics. Anesth Analg. 1995; 80:1145–1149. PMID:
7762842.
Article
5. Segerdahl M, Persson E, Ekblom A, Sollevi A. Peroperative adenosine infusion reduces isoflurane concentrations during general anesthesia for shoulder surgery. Acta Anaesthesiol Scand. 1996; 40:792–797. PMID:
8874564.
Article
6. Segerdahl M, Irestedt L, Sollevi A. Antinociceptive effect of perioperative adenosine infusion in abdominal hysterectomy. Acta Anaesthesiol Scand. 1997; 41:473–479. PMID:
9150774.
Article
7. Thompson JP, Rowbotham DJ. Remifentanil--an opioid for the 21st century. Br J Anaesth. 1996; 76:341–343. PMID:
8785129.
Article
8. Fletcher D, Pinaud M, Scherpereel P, Clyti N, Chauvin M. The efficacy of intravenous 0.15 versus 0.25 mg/kg intraoperative morphine for immediate postoperative analgesia after remifentanil-based anesthesia for major surgery. Anesth Analg. 2000; 90:666–671. PMID:
10702454.
Article
9. Fukunaga AF, Alexander GE, Stark CW. Characterization of the analgesic actions of adenosine: comparison of adenosine and remifentanil infusions in patients undergoing major surgical procedures. Pain. 2003; 101:129–138. PMID:
12507707.
Article
10. Hayashida M, Fukuda K, Fukunaga A. Clinical application of adenosine and ATP for pain control. J Anesth. 2005; 19:225–235. PMID:
16032451.
Article
11. Seitz PA, ter Riet M, Rush W, Merrell WJ. Adenosine decreases the minimum alveolar concentration of halothane in dogs. Anesthesiology. 1990; 73:990–994. PMID:
2240689.
Article
12. Cronstein BN. Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol. 1994; 76:5–13. PMID:
8175547.
Article
13. Montesinos MC, Desai A, Delano D, Chen JF, Fink JS, Jacobson MA, et al. Adenosine A2A or A3 receptors are required for inhibition of inflammation by methotrexate and its analog MX-68. Arthritis Rheum. 2003; 48:240–247. PMID:
12528125.
Article
14. Rane K, Sollevi A, Segerdahl M. Intrathecal adenosine administration in abdominal hysterectomy lacks analgesic effect. Acta Anaesthesiol Scand. 2000; 44:868–872. PMID:
10939701.
Article
15. Rane K, Sollevi A, Segerdahl M. A randomised double-blind evaluation of adenosine as adjunct to sufentanil in spinal labour analgesia. Acta Anaesthesiol Scand. 2003; 47:601–603. PMID:
12699520.
Article
16. Seymour RA, Hawkesford JE, Hill CM, Frame J, Andrews C. The efficacy of a novel adenosine agonist (WAG 994) in postoperative dental pain. Br J Clin Pharmacol. 1999; 47:675–680. PMID:
10383546.
Article
17. Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology. 2006; 104:570–587. PMID:
16508405.
Article
18. Yaksh TL, Harty GJ, Onofrio BM. High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications. Anesthesiology. 1986; 64:590–597. PMID:
2938524.
Article
19. Van Elstraete AC, Sitbon P, Mazoit JX, Conti M, Benhamou D. Protective effect of prior administration of magnesium on delayed hyperalgesia induced by fentanyl in rats. Can J Anaesth. 2006; 53:1180–1185. PMID:
17142651.
Article
20. Nörenberg W, Wirkner K, Assmann H, Richter M, Illes P. Adenosine A2A receptors inhibit the conductance of NMDA receptor channels in rat neostriatal neurons. Amino Acids. 1998; 14:33–39. PMID:
9871438.
Article